FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4298001711> ?p ?o ?g. }

• W4298001711 abstract "Background: The pain pattern after laparoscopic cholecystectomy (LC) is complex and distinct from postoperative pain after other laparoscopic procedures, suggesting that procedure-specific optimal analgesic management plans should be proposed. Duloxetine, a non-opioid neuromodulator, has been widely used to manage pain with dual central and peripheral analgesic properties. Aims: To assess the effect of preoperative administration of duloxetine compared to placebo on postoperative pain control in patients undergoing LC. Patients and Methods: This study was a randomized, parallel-group, placebo-controlled, double-blinded study performed on patients undergoing LC. Patients were randomly divided into two groups of 30 each on the day of surgery in the preoperative holding area, using a computer-generated random number to receive 60 mg duloxetine as a single oral dose 2 h before the procedure or placebo. The primary outcome was the difference in the mean of visual analogue scale (VAS) scores between the two studied groups, as measured by the area under the curve (AUC) of the VAS scores. Results: The derived AUC of VAS scores in the duloxetine group (757.89 ± 326.01 mm × h) was significantly lower than that calculated for the control group (1005.1 ± 432.5 mm × h). The mean postoperative VAS scores recorded at 4 and 24 h were statistically different between the study groups (p = 0.041 and 0.003, respectively). As observed in the survival curve analysis, there was no significant difference (p = 0.665) for the time until the patient's first request for rescue medications in the two groups. The frequency of postoperative nausea and vomiting (PONV) was lower in patients of the duloxetine group than that recorded in those allocated to the control group at 8 and 24-h time intervals (p = 0.734 and 0.572, respectively). Conclusion: Preoperative use of duloxetine reduces postoperative pain significantly compared with placebo. In addition, its use is associated with a reduction in PONV. These preliminary findings suggest that duloxetine could play a role in the acute preoperative period for patients undergoing LC. Clinical Trial Registration: [https://clinicaltrials.gov/ct2/show/NCT05115123, identifier NCT05115123]." @default.
• W4298001711 created "2022-10-01" @default.
• W4298001711 creator A5006342139 @default.
• W4298001711 creator A5007352775 @default.
• W4298001711 creator A5070231367 @default.
• W4298001711 creator A5073302900 @default.
• W4298001711 creator A5083702506 @default.
• W4298001711 creator A5084166770 @default.
• W4298001711 creator A5084389093 @default.
• W4298001711 date "2022-09-29" @default.
• W4298001711 modified "2023-10-04" @default.
• W4298001711 title "Evaluation of preoperative duloxetine use for postoperative analgesia following laparoscopic cholecystectomy: A randomized controlled trial" @default.
• W4298001711 cites W1128286088 @default.
• W4298001711 cites W1486540448 @default.
• W4298001711 cites W1869121217 @default.
• W4298001711 cites W1983461214 @default.
• W4298001711 cites W1998253293 @default.
• W4298001711 cites W2002211622 @default.
• W4298001711 cites W2002671228 @default.
• W4298001711 cites W2026756785 @default.
• W4298001711 cites W2031955247 @default.
• W4298001711 cites W2043859702 @default.
• W4298001711 cites W2055846831 @default.
• W4298001711 cites W2071200288 @default.
• W4298001711 cites W2074508240 @default.
• W4298001711 cites W2088221967 @default.
• W4298001711 cites W2100082403 @default.
• W4298001711 cites W2103262865 @default.
• W4298001711 cites W2105963978 @default.
• W4298001711 cites W2113578435 @default.
• W4298001711 cites W2118132357 @default.
• W4298001711 cites W2160489474 @default.
• W4298001711 cites W2163466684 @default.
• W4298001711 cites W2164163873 @default.
• W4298001711 cites W2191933700 @default.
• W4298001711 cites W2582844629 @default.
• W4298001711 cites W2594499642 @default.
• W4298001711 cites W2784128174 @default.
• W4298001711 cites W2884761363 @default.
• W4298001711 cites W2885559620 @default.
• W4298001711 cites W2888597357 @default.
• W4298001711 cites W2936607468 @default.
• W4298001711 cites W2950460149 @default.
• W4298001711 cites W2966419739 @default.
• W4298001711 cites W2998715889 @default.
• W4298001711 cites W3000647500 @default.
• W4298001711 cites W3001157776 @default.
• W4298001711 cites W3080842035 @default.
• W4298001711 cites W3085758362 @default.
• W4298001711 cites W3161553200 @default.
• W4298001711 cites W3184262397 @default.
• W4298001711 cites W3208810587 @default.
• W4298001711 cites W3210592907 @default.
• W4298001711 cites W4220653850 @default.
• W4298001711 doi "https://doi.org/10.3389/fphar.2022.944392" @default.
• W4298001711 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36249765" @default.
• W4298001711 hasPublicationYear "2022" @default.
• W4298001711 type Work @default.
• W4298001711 citedByCount "4" @default.
• W4298001711 countsByYear W42980017112023 @default.
• W4298001711 crossrefType "journal-article" @default.
• W4298001711 hasAuthorship W4298001711A5006342139 @default.
• W4298001711 hasAuthorship W4298001711A5007352775 @default.
• W4298001711 hasAuthorship W4298001711A5070231367 @default.
• W4298001711 hasAuthorship W4298001711A5073302900 @default.
• W4298001711 hasAuthorship W4298001711A5083702506 @default.
• W4298001711 hasAuthorship W4298001711A5084166770 @default.
• W4298001711 hasAuthorship W4298001711A5084389093 @default.
• W4298001711 hasBestOaLocation W42980017111 @default.
• W4298001711 hasConcept C126322002 @default.
• W4298001711 hasConcept C141071460 @default.
• W4298001711 hasConcept C14184104 @default.
• W4298001711 hasConcept C142724271 @default.
• W4298001711 hasConcept C168563851 @default.
• W4298001711 hasConcept C170493617 @default.
• W4298001711 hasConcept C204787440 @default.
• W4298001711 hasConcept C27081682 @default.
• W4298001711 hasConcept C2776641081 @default.
• W4298001711 hasConcept C2780744026 @default.
• W4298001711 hasConcept C2780764818 @default.
• W4298001711 hasConcept C2780820201 @default.
• W4298001711 hasConcept C2781063702 @default.
• W4298001711 hasConcept C2910564767 @default.
• W4298001711 hasConcept C2987287001 @default.
• W4298001711 hasConcept C42219234 @default.
• W4298001711 hasConcept C71924100 @default.
• W4298001711 hasConcept C76318530 @default.
• W4298001711 hasConcept C98274493 @default.
• W4298001711 hasConceptScore W4298001711C126322002 @default.
• W4298001711 hasConceptScore W4298001711C141071460 @default.
• W4298001711 hasConceptScore W4298001711C14184104 @default.
• W4298001711 hasConceptScore W4298001711C142724271 @default.
• W4298001711 hasConceptScore W4298001711C168563851 @default.
• W4298001711 hasConceptScore W4298001711C170493617 @default.
• W4298001711 hasConceptScore W4298001711C204787440 @default.
• W4298001711 hasConceptScore W4298001711C27081682 @default.
• W4298001711 hasConceptScore W4298001711C2776641081 @default.
• W4298001711 hasConceptScore W4298001711C2780744026 @default.
• W4298001711 hasConceptScore W4298001711C2780764818 @default.
• W4298001711 hasConceptScore W4298001711C2780820201 @default.

• next